Keywords: promising, new, data, sciclone, zadaxin, usa-based, pharmaceuticals
Promising new data for SciClone's Zadaxin
Article | 01 March 2004
USA-based SciClone Pharmaceuticals has reported positive interim findings from a pilot clinical trial evaluating a new triple therapy comprising its ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
